Pictet Asset Management Holding SA Sells 181,518 Shares of Danaher Corporation $DHR

Key Points

• Pictet Asset Management Holding SA reduced its Danaher stake by 21.5%, selling 181,518 shares in Q4 and now holds 664,403 shares valued at about $152.1 million (roughly 0.09% of the company).
• Danaher beat quarterly EPS expectations—$2.06 vs. $1.94 consensus—while revenue slightly missed at $5.95 billion, and the company set FY2026 guidance of 8.350–8.550 EPS (analysts forecast ~8.43).
• Danaher raised its quarterly dividend to $0.40 (annualized $1.60, ~0.9% yield), and the stock carries an average analyst rating of "Moderate Buy" with an average price target of $240.70.

Pictet Asset Management Holding SA lowered its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 21.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 664,403 shares of the conglomerate's stock after selling 181,518 shares during the quarter. Pictet Asset Management Holding SA owned about 0.09% of Danaher worth $152,118,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of DHR. Sivia Capital Partners LLC grew its position in Danaher by 6.3% in the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate's stock valued at $397,000 after purchasing an additional 119 shares during the period. First Trust Advisors LP grew its position in Danaher by 34.5% in the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate's stock valued at $10,947,000 after purchasing an additional 14,217 shares during the period. Main Street Financial Solutions LLC grew its position in Danaher by 40.2% in the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate's stock valued at $610,000 after purchasing an additional 886 shares during the period. Ieq Capital LLC grew its position in Danaher by 64.2% in the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate's stock valued at $14,957,000 after purchasing an additional 29,592 shares during the period. Finally, HUB Investment Partners LLC grew its position in Danaher by 30.7% in the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate's stock valued at $273,000 after purchasing an additional 325 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Price Performance

Shares of NYSE:DHR opened at $180.84 on Tuesday. The company's 50-day moving average is $195.12 and its 200 day moving average is $213.79. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The company has a market capitalization of $127.99 billion, a P/E ratio of 34.98, a price-to-earnings-growth ratio of 2.37 and a beta of 0.95. Danaher Corporation has a fifty-two week low of $175.00 and a fifty-two week high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, April 21st. The conglomerate reported $2.06 earnings per share for the quarter, topping analysts' consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm's quarterly revenue was up 3.7% on a year-over-year basis. During the same period in the previous year, the firm earned $1.88 EPS. Danaher has set its FY 2026 guidance at 8.350-8.550 EPS. On average, equities research analysts forecast that Danaher Corporation will post 8.43 earnings per share for the current year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 24th. Investors of record on Friday, March 27th were issued a $0.40 dividend. This is an increase from Danaher's previous quarterly dividend of $0.32. The ex-dividend date of this dividend was Friday, March 27th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. Danaher's payout ratio is presently 30.95%.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the stock. Argus reduced their price target on shares of Danaher from $265.00 to $230.00 and set a "buy" rating for the company in a research report on Friday. Wall Street Zen downgraded shares of Danaher from a "buy" rating to a "hold" rating in a research report on Saturday. Jefferies Financial Group reissued a "buy" rating and issued a $245.00 price target on shares of Danaher in a research report on Tuesday, April 21st. Wells Fargo & Company reduced their price target on shares of Danaher from $240.00 to $212.00 and set an "equal weight" rating for the company in a research report on Wednesday, April 22nd. Finally, Robert W. Baird reduced their price target on shares of Danaher from $251.00 to $249.00 and set an "outperform" rating for the company in a research report on Friday, April 17th. Eighteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $240.70.

Insider Buying and Selling at Danaher

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the business's stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the transaction, the executive vice president directly owned 5,099 shares of the company's stock, valued at approximately $1,060,642.99. The trade was a 20.56% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 10.80% of the company's stock.

Danaher Company Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.